Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective
AUTOR(ES)
Okumura, Lucas Miyake
FONTE
Braz J Infect Dis
DATA DE PUBLICAÇÃO
2016-08
RESUMO
Documentos Relacionados
- Histoplasmosis: A review, and account of three patients diagnosed in Great Britain
- Oral candidiasis in HIV+ patients under treatment with protease inhibitors
- Head and Neck Lymphomas in HIV Patients: a Clinical Perspective
- Chronic meningitis by histoplasmosis: report of a child with acute myeloid leukemia
- HIV protease inhibitors and atherosclerosis